Groupe BSH | Biomedical Engineering

Infiplast Biomedical – firstly called Plastics then renamed as BioMedical – is a specialist in white room plastic injection moulding for the medical sector. In the next few years, this sector will be making more use of plastics due to the multitude of benefits:

  • The optimisation of asepsis rules: Ease of cleaning and decontamination, disposable properties for certain materials.

  • The development of new treatments, in particular for orphan diseases, kidney diseases, etc.

  • Progress and continuous innovation on these materials:
    Bio-compatibility, bio-degradability, nanotechnologies, sterilisation capacity, etc.

  • Improvement in the quality of care: Outpatient surgery,
    Fight against nosocomial infections

  • Development of preventive medicine by diagnosis

  • Better cost-effectiveness than other materials.

    The BSH Group is well situated in Plastic Valley, one of the first European plastics clusters. This business park features a dense network of SME-SMIs, including raw materials suppliers, machine and equipment manufacturers, moulders, transformers, training organisations, research centres and the Plastipolis competitiveness cluster. Working in such a network enables the group to innovate and organise the partnership strategies required for its development.

 

Plasturgiste secteur médical, conception pièces thermoplastiques, pièces plastiques pharmaceutique,ISO 13485, Transformateur en salle blanche, Injecteur en salle blanche.

Infiplast Biomedical quality certifications

Infiplast Biomedical quality certifications
Innovative solutions are born from this innovation process. As an example, the syringe designed and developed by Infiplast Biomedical for Biomatlante, who manufacture and distribute 100% synthetic dual-phase bone substitutes. This company designed an injectable synthetic bone filler material. It needed a specific syringe to be able to inject the dual-phase material (liquid and powder) into the patient.
The syringe had to offer features such as ensuring the homogeneity of the two phases and the sterility of the material during preparation. Together with the Biomatlante project team, the Infiplast Biomedical R&D team optimised the manufacturing process and developed the product design. Lastly, each company's quality department integrated the regulatory requirements in terms of bio-contamination risk right from the design phase.

ISO TS 16949, an international standard applicable to automobile makers. Quality is an essential component of our policy: Material vigilance, qualification, product control, traceability.


iso 9001 iso ts 16949iso 13485

Certifications
- ISO 9001 version 2008,
- ISO TS 16949 version 2009,
- ISO 13485 version 2012.

In brief

from the 6th to the 9th of December 2016

MIDEST 2016

Christine BLACK 06 73 52 34 27, and Alain LECOMTE will welcome you on the INFIPLAST Booth N°138 Hall 6 'Allée' E

www.infiplast.com


from 22 to 26 November 2016

ADF DENTAL CONGRESS 2016 in PARIS

INFIPLAST Would enjoy to welcome you on its booth N° 4M10 PARIS 'Porte MAILLOT' Your contacts are: Alain LECOMTE: +33(0)673 535 598 Christine BLACK

www.infiplast.com


> View all news

> View newsletter 4

 

HOME

Infiplast I BiomEdical
Infiplast : A word from the chairman I Quality & Management I Biomedical Engineering I
Infrastructures I Laboratory
News / Press
Surgery
Ophtalmology / Neurology
Diagnosis
Laboratories
Biomedical
Contact



Infiplast I Groupe BSH
Infiplast : A word from the chairman I Quality & Management I Infrastructures
News
Engineering
Process
Video
Contact

Legal notice • Design : artenium